William Wallace: Hidden Vitamin B12 Deficiency and Better Testing Methods
William Wallace, Co-Founder and Chief Scientific Officer at Supplement Success Solutions, shared a post on X about a recent article by Ralph Carme, published in The American Journal of Clinical Nutrition, adding:
“Your B12 test measures two things and cannot distinguish between them.
Seventy to eighty percent of circulating vitamin B12 is bound to haptocorrin. The liver clears this fraction, and it never reaches the cells.
Twenty to thirty percent is bound to transcobalamin. This is the biologically active fraction that is actually delivered to tissues.
Clinicians refer to it as holo transcobalamin.
Standard serum vitamin B12 tests add both fractions together. A result that appears ‘normal’ can still mask a cellular deficiency, and these
tests miss approximately twenty-five to thirty percent of true deficiency cases.
The better tests are:
- Holo transcobalamin, which directly measures the active fraction
- Methylmalonic acid, which rises only when cellular vitamin B12 is truly insufficient and is considered a functional gold standard
- Homocysteine, which also rises in deficiency but is less specific because it can also increase with low folate, low vitamin B6, mthfr variants, kidney issues, aging. Less specific.
Who should care: adults over sixty years of age, long-term metformin users (ten to thirty percent develop deficiency), proton
pump inhibitor users, vegetarians and vegans, and anyone with unexplained fatigue, neuropathy, cognitive changes, or macrocytic anemia.
If vitamin B12 is reported as normal but symptoms do not match, it is reasonable to request holo transcobalamin and methylmalonic acid
testing.”
Title: Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II
Authors: Ralph Carme
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 18:19Nabil Tabish: The Paradox of Zero – Investigating Extreme VWF Discordance
-
Jun 27, 2026, 18:19Francesco Favruzzo: Can Mechanical Thrombectomy Be Safely Used in Cervical Artery Dissection?
-
Jun 27, 2026, 18:18Vera Ghali: 2026 ASH–ISTH Recommendations on Pediatric VTE Prevention
-
Jun 27, 2026, 18:17Michiel Coppens: A Hemostasis Laboratory – One of the Cornerstones of Our Hemophilia Mission
-
Jun 27, 2026, 18:16Sthanu Subramanian: Dabigatran and Mechanical Heart Valves
-
Jun 27, 2026, 15:50Muhammet Özbilen: The Skin as an Emerging Regulator of Iron Homeostasis
-
Jun 27, 2026, 15:07Anteneh Berhane: Supporting Healthier Pregnancies Through Early Nutrition
-
Jun 27, 2026, 14:35Mobina Nakhaei: Why Alloantibodies Develop Despite ABO/Rh Matching in Thalassemia
-
Jun 27, 2026, 14:01Abdul Mannan: DOACs in Cancer-Associated VTE – When to Avoid Them, And When LMWH Wins